Lotus Lake Ventures

Lotus Lake Ventures is a Beijing-based boutique fund that focuses on early-stage opportunities in healthcare software and clinical data infrastructure. The firm targets digital health and health IT companies, an emphasis aligned with the rapid digitization of Chinese hospital systems, payer workflows, and pharma R&D. Lotus Lake operates with a small footprint, and limited public information is available regarding fund size, named partners, or specific portfolio companies, so founders engaging the firm should expect to learn about its thesis through direct conversation rather than extensive published material.

The fund participates at Seed and Series A, with check sizes typically in the two hundred fifty thousand to one million dollar band. Investments concentrate on the Chinese market, where Beijing’s role as a regulatory, academic, and hospital center provides natural deal flow in clinical software and data management. Founders raising small first institutional rounds, particularly those building B2B tools for hospitals, research institutes, or biotech operators, are the kind of company the firm appears positioned to back.

Given the boutique structure and absence of detailed public commentary from individual partners, founders should expect a relationship-driven process rather than a programmatic platform offering. The firm is likely most useful as a local lead or co-investor for companies that need a knowledgeable Chinese institutional partner at an early stage, with follow-on participation and value-add depending on individual deal dynamics. Specific founder support practices, board norms, and decision speed are not documented publicly and would need to be evaluated through direct engagement and reference checks with prior portfolio founders.